Supplementary data from: Effect of mass azithromycin distribution on antibiotic resistance in the gut and nasopharynx: A cluster-randomized trial

Read full text
Authors: Thuy A. Doan, Daisy Danielle Yan, Ahmed Mamane Arzika, Abdou Amza, Ramatou Maliki, Bawa Aichatou, Ismael Mamane Bello, Diallo Beidi, Nasser Galo, Naser Harouna, Alio M Karamba, Sani Mahamadou
+16 more Moustapha Abarchi, Almou Ibrahim, Lina Zhong, Cindi Chen, YuHeng Liu, Danny Yu, Thomas Abraham, Angela S. Cheng, Brittany Faye Peterson, Catherine Oldenburg, Travis C. Porco, B. C. Arnold, Armin J. Hinterwirth, Elodie Lebas, Kieran O'Brien, Thomas Lietman
Cited by: 1

Abstract

The data contained in this repository was collected as part of a trial that studies the effects of repeated twice-yearly azithromycin mass drug distribution (MDA) in a pediatric population enrolled in a clinical trial in Niger. MDA has been shown to reduce all-cause childhood mortality, but the potential selection of antibiotic resistance (AMR) is a major public health concern. The repository contains supporting material describing the sequencing quality of samples, while the host-cleaned sequencing data itself can be found in the Sequencing Read Archive (SRA) under BioProject ID PRJNA1337442.

Publication details

Journal / source
DRYAD
Publication date
9 January 2026
Language
EN